Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Report 2021

In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of radioisotopes. Advancements made in the areas of chemiluminescence and fluorescence have allowed for an easier transition. In non-radioactive assays, signal is generated through an enzymatic reaction with a chemiluminescent or chromogenic substrate; alternatively, detection can occur through the appropriate excitation and emission of a fluorophore-labeled probe.
The classification of non-radioactive nucleic acid labeling product includes biotin, DIG system, fluorescent and others. The proportion of DIG system in 2017 is about 33%, and the proportion is in increasing trend from 2013 to 2017.

Market Analysis and Insights: Global Non-Radioactive Nucleic Acid Labeling Product Market
The global Non-Radioactive Nucleic Acid Labeling Product market was valued at US$ 315.4 in 2020 and will reach US$ 470.7 million by the end of 2027, growing at a CAGR of 6.9% during 2022-2027.

Global Non-Radioactive Nucleic Acid Labeling Product Scope and Market Size
The global Non-Radioactive Nucleic Acid Labeling Product market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Radioactive Nucleic Acid Labeling Product market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Biotin
DIG System
Fluorescent
Others

Segment by Application
DNA Labeling
RNA Labeling
Oligonucleotide Labeling

The Non-Radioactive Nucleic Acid Labeling Product market is analysed and market size information is provided by regions (countries). Segment by Application, the Non-Radioactive Nucleic Acid Labeling Product market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Thermo Fisher Scientific
Roche
Promega
PerkinElmer
Agilent Technologies
General Electric
Enzo Biochem
Merck KGaA
Vector Labs
New England Biolabs

Frequently Asked Questions